As part of a humanitarian effort responding to the ongoing crisis in Ukraine, Marken was requested by a client to ship critical compassionate use medicinal products and supplies.

• These requested clinical supplies were currently not available in the region to aid Ukrainian refugees.
• These shipments required a 48-turnaround time (TAT) in order to stay within temperature specifications and reach the patient on-time as these critical medicines can be lifesaving.
• Compassionate treatments have complex regulatory hurdles, specific logistical requirements and personalized needs.
• Being a war zone, air transport and routine logistics operations have been severely affected in and out of Ukraine.

To mitigate the supply chain and regulatory challenges, Marken’s dedicated Early Access Programs (EAP) team collaborated to devise a customized and safe routing solution. Working closely with the client, Marken outlined route risk assessment and compliance clearance processes to ensure delivery within crucial lead-time.

Marken’s EAP team immediately started working with a local LSP in Poland to assist customs clearance via the Polish Ministry of Health (MOH). Together, Marken and the Polish government agency body, RARS, productively expedited the importation of the compassionate critical shipments under humanitarian aid and organized road transportation from Poland into Ukraine directly to the Ukrainian MOH.

To safeguard the temperature of these critical shipments at 2̊ to 8̊ and 15̊ to 25̊ Celsius, Marken provided preconditioned temperature-controlled packaging and shipping solutions. By placing GPS devices on the outside cartons for real-time location and temperature tracking, complete chain of custody was delivered and maintained throughout the shipment journey.

The shipments arrived at the Ukraine MOH safely, at the required temperature specifications, while exceeding the 48-hour lead-time with an overall 43-hour TAT deliverable performance. The compassionate life-saving medicines and supplies were successfully distributed to the patients and refugees who urgently needed them.

Marken offers a state-of-the-art GMP-compliant depot network and logistic hubs for clinical drug product storage and distribution in 46 locations worldwide, while maintaining the leading position for cell and gene therapy services, direct-to-patient and home healthcare services, biological sample shipments and biological kit production. Marken’s dedicated 2,600+ staff members manage 200,000 drug product and biological sample shipments every month at all temperature ranges in more than 220 countries and territories and have orchestrated 17,500+ home healthcare visits. Additional services such as ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.

Delivering What Matters From Clinical to Commercial.